Nadler adds
Clinical studies indicate that in individuals with T2DM and obesity, oral semaglutide at a dose of 14 mg can improve HbA1c levels by up to 1.4% and reduce body weight by approximately 4.4 kg
For those who are truly resistant, hormonal causes to screen for: 1
doi:10.1186/s12902-023-01500-5
Efinopepgutida: en un ensayo fase 2 de 145 participantes con IMC inicial de 34,3kg/m2 (33,1% con DM2) efinopepgutida 10mg respecto a semaglutida 1mg mostr una mayor reduccin del contenido de grasa heptica evaluada por resonancia en 24 semanas (72,7% frente a 42,3%, respectivamente) con una prdida de peso similar (8,5% frente a 7,1%, respectivamente)29
Gastrointestinal issues Bodybuilders experiencing gut issues from NSAID use, supplement-related inflammation, or digestive stress benefit from BPC-157s protective effects on the GI tract